BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29984665)

  • 1. The Influence of Pre-Analytical Factors on the Analysis of Circulating MicroRNA.
    Shiotsu H; Okada K; Shibuta T; Kobayashi Y; Shirahama S; Kuroki C; Ueda S; Ohkuma M; Ikeda K; Ando Y; Matsui H; Kayamori Y; Umemura T
    Microrna; 2018; 7(3):195-203. PubMed ID: 29984665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiRNA profiles in blood plasma from mother-child duos in human biobanks and the implication of sample quality: Circulating miRNAs as potential early markers of child health.
    Dypås LB; Gützkow KB; Olsen AK; Duale N
    PLoS One; 2020; 15(4):e0231040. PubMed ID: 32240265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Standardization of Plasma Preparation for MicroRNA Analysis: Influences of High Speed Centrifugation and Membrane Filtration].
    Shiraihama S; Kobayashi Y; Kuroki C; Hirotsu M; Okada K; Shibuta T; Shiotsu H; Hotta T; Kang D; Umemura T
    Rinsho Byori; 2017 Mar; 65(3):260-265. PubMed ID: 30802008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved Detection of Circulating miRNAs in Serum and Plasma Following Rapid Heat/Freeze Cycling.
    Mariner PD; Korst A; Karimpour-Fard A; Stauffer BL; Miyamoto SD; Sucharov CC
    Microrna; 2018; 7(2):138-147. PubMed ID: 29658445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra-individual variation of miRNA expression levels in human plasma samples.
    Wu J; Cai H; Xiang YB; Matthews CE; Ye F; Zheng W; Cai Q; Shu XO
    Biomarkers; 2018; 23(4):339-346. PubMed ID: 29378466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variability in microRNA recovery from plasma: Comparison of five commercial kits.
    Brunet-Vega A; Pericay C; Quílez ME; Ramírez-Lázaro MJ; Calvet X; Lario S
    Anal Biochem; 2015 Nov; 488():28-35. PubMed ID: 26271186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in metabolite profiles caused by pre-analytical blood processing procedures.
    Nishiumi S; Suzuki M; Kobayashi T; Yoshida M
    J Biosci Bioeng; 2018 May; 125(5):613-618. PubMed ID: 29258730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma processing conditions substantially influence circulating microRNA biomarker levels.
    Cheng HH; Yi HS; Kim Y; Kroh EM; Chien JW; Eaton KD; Goodman MT; Tait JF; Tewari M; Pritchard CC
    PLoS One; 2013; 8(6):e64795. PubMed ID: 23762257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of circulating miRNAs in patients with familial hypercholesterolaemia treated by LDL/Lp(a) apheresis.
    Dlouha D; Blaha M; Blaha V; Fatorova I; Hubacek JA; Stavek P; Lanska V; Parikova A; Pitha J
    Atheroscler Suppl; 2017 Nov; 30():128-134. PubMed ID: 29096828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of Circulating Blood-Based MicroRNAs - Pre-Analytic Methodological Considerations.
    Glinge C; Clauss S; Boddum K; Jabbari R; Jabbari J; Risgaard B; Tomsits P; Hildebrand B; Kääb S; Wakili R; Jespersen T; Tfelt-Hansen J
    PLoS One; 2017; 12(2):e0167969. PubMed ID: 28151938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Future-Proofing" Blood Processing for Measurement of Circulating miRNAs in Samples from Biobanks and Prospective Clinical Trials.
    Murray MJ; Watson HL; Ward D; Bailey S; Ferraresso M; Nicholson JC; Gnanapragasam VJ; Thomas B; Scarpini CG; Coleman N
    Cancer Epidemiol Biomarkers Prev; 2018 Feb; 27(2):208-218. PubMed ID: 29254935
    [No Abstract]   [Full Text] [Related]  

  • 12. Hyperglycaemia suppresses microRNA expression in platelets to increase P2RY12 and SELP levels in type 2 diabetes mellitus.
    Fejes Z; Póliska S; Czimmerer Z; Káplár M; Penyige A; Gál Szabó G; Beke Debreceni I; Kunapuli SP; Kappelmayer J; Nagy B
    Thromb Haemost; 2017 Feb; 117(3):529-542. PubMed ID: 27975100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disparate miRNA expression in serum and plasma of patients with acute myocardial infarction: a systematic and paired comparative analysis.
    Mompeón A; Ortega-Paz L; Vidal-Gómez X; Costa TJ; Pérez-Cremades D; Garcia-Blas S; Brugaletta S; Sanchis J; Sabate M; Novella S; Dantas AP; Hermenegildo C
    Sci Rep; 2020 Mar; 10(1):5373. PubMed ID: 32214121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of the Anticoagulant Type in Blood Collection Tubes on Circulating Extracellular Plasma MicroRNA Profiles Revealed by Small RNA Sequencing.
    Zhelankin AV; Iulmetova LN; Sharova EI
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive Analysis of Circulating microRNA Specific to the Liver, Heart, and Skeletal Muscle of Cynomolgus Monkeys.
    Iguchi T; Niino N; Tamai S; Sakurai K; Mori K
    Int J Toxicol; 2017; 36(3):220-228. PubMed ID: 28460582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preanalytic Methodological Considerations and Sample Quality Control of Circulating miRNAs.
    Chan SF; Cheng H; Goh KK; Zou R
    J Mol Diagn; 2023 Jul; 25(7):438-453. PubMed ID: 37030398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of commercial exosome isolation kits for circulating exosomal microRNA profiling.
    Ding M; Wang C; Lu X; Zhang C; Zhou Z; Chen X; Zhang CY; Zen K; Zhang C
    Anal Bioanal Chem; 2018 Jun; 410(16):3805-3814. PubMed ID: 29671027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating microRNA profiles in plasma: identification of miR-224 as a novel diagnostic biomarker in hepatocellular carcinoma independent of hepatic function.
    Okajima W; Komatsu S; Ichikawa D; Miyamae M; Kawaguchi T; Hirajima S; Ohashi T; Imamura T; Kiuchi J; Arita T; Konishi H; Shiozaki A; Moriumura R; Ikoma H; Okamoto K; Taniguchi H; Itoh Y; Otsuji E
    Oncotarget; 2016 Aug; 7(33):53820-53836. PubMed ID: 27462777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of circulating microRNA: preanalytical and analytical challenges.
    McDonald JS; Milosevic D; Reddi HV; Grebe SK; Algeciras-Schimnich A
    Clin Chem; 2011 Jun; 57(6):833-40. PubMed ID: 21487102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of reference miRNAs in plasma useful for the study of oestrogen-responsive miRNAs associated with acquired Protein S deficiency in pregnancy.
    Tay JW; James I; Hughes QW; Tiao JY; Baker RI
    BMC Res Notes; 2017 Jul; 10(1):312. PubMed ID: 28743297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.